欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号AT/H/0535/004
药品名称Olmesartan/HCT Sandoz 20 mg/25 mg - Filmtabletten
活性成分
    • hydrochlorothiazide 25.0 mg
    • olmesartan medoxomil 40.0 mg
剂型Film-coated tablet
上市许可持有人Sandoz GmbH Biochemiestrasse 10 6250 Kundl Austria
参考成员国 - 产品名称Austria (AT)
Olmesartan/HCT Sandoz 40 mg/25 mg - Filmtabletten
互认成员国 - 产品名称
    • Belgium (BE)
    • Netherlands (NL)
    • Italy (IT)
    • Portugal (PT)
    • Greece (GR)
      OLMESARTAN MEDOXOMIL+HCTZ/SANDOZ
许可日期2015/04/30
最近更新日期2024/04/29
药物ATC编码
    • C09DA08 olmesartan medoxomil and diuretics
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase